Unveiling the rise of Candida auris: Latest developments and healthcare implications

---

Review Article

Author Details : Swathi Gurajala*

Volume : 10, Issue : 3, Year : 2024

Article Page : 196-205

https://doi.org/10.18231/j.ijmmtd.2024.035

Suggest article by email

Get Permission

---

Abstract

Candida auris, a fungus that is resistant to multiple drugs, has become a major global healthcare concern in recent years. The pathogen quickly disseminates within healthcare facilities, colonizes many surfaces, and leads to recurrent infections despite frequent disinfection measures. Automated systems frequently misidentify it, resulting in a delayed diagnosis. Inadequate hand hygiene, the use of multiple antibiotics, and contaminated medical equipment are the main causes of infections that primarily target critically ill patients in hospital intensive care units (ICUs). Candida auris isolates are resistant to commonly used antifungal
drugs like fluconazole, amphotericin, and echinocandins. This review article thoroughly examines the current understanding of Candida auris infections, encompassing its epidemiology, clinical symptoms, diagnosis, treatment options, and prevention measures. It additionally summarizes a recent literature review on emerging diagnostic techniques and treatment options. Gaining a comprehensive understanding of the difficulties presented by this pathogen and staying informed of the most recent  developments is essential for healthcare providers and policymakers in order to efficiently counteract its transmission and limit its
detrimental impact on patient health.

Keywords: Candida auris, C.auris diagnostics, C. auris treatment, C. auris antifungal resistance, C. auris infection control

How to cite : Gurajala S, Unveiling the rise of Candida auris: Latest developments and healthcare implications. IP Int J Med Microbiol Trop Dis 2024;10(3):196-205

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.